Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1975 Aug;37(8):790–794. doi: 10.1136/hrt.37.8.790

Serum lipids in young female survivors of myocardial infarction.

J I Mann, M Thorogood
PMCID: PMC482876  PMID: 172096

Abstract

Fasting serum lipids and lipoprotein patterns were studied in 44 female survivors of acute myocardial infarction under the age of 45 years, and in 84 matched control subjects. Type II hyperlipoproteinaemia was present in 41 per cent of the myocardial infarction patients and in none of the controls. There was, however, no difference in the prevalence of the type IV abnormality, which was present in 7 per cent of the myocardial infarction patients and 8 per cent of the control subjects. Mean cholesterol and triglyceride levels were both significantly higher in the women who had survived myocardial infarction than in the controls; the difference in triglyceride was attributable to the type IIb abnormality which occurred in 11 per cent of these patients. It is suggested that ovarian hormones may protect premenopausal women from type IV hyperlipoproteinaemia and its possible atherogenic sequelae.

Full text

PDF
790

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown D. F., Daudiss K. Hyperlipoproteinemia. Prevalence in a free-living population in Albany, New York. Circulation. 1973 Mar;47(3):558–566. doi: 10.1161/01.cir.47.3.558. [DOI] [PubMed] [Google Scholar]
  2. CARLSON L. A. Serum lipids in men with myocardial infarction. Acta Med Scand. 1960 Aug 31;167:399–413. doi: 10.1111/j.0954-6820.1960.tb03562.x. [DOI] [PubMed] [Google Scholar]
  3. Carlson L. A., Böttiger L. E. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet. 1972 Apr 22;1(7756):865–868. doi: 10.1016/s0140-6736(72)90738-6. [DOI] [PubMed] [Google Scholar]
  4. Eggstein M., Kreutz F. H. Eine neue Bestimmung der Neutralfette im Blutserum und Gewebe. I. Prinzip, Durchführung und Besprechung der Methode. Klin Wochenschr. 1966 Mar 1;44(5):262–267. doi: 10.1007/BF01747716. [DOI] [PubMed] [Google Scholar]
  5. Garcia M. J., McNamara P. M., Gordon T., Kannel W. B. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974 Feb;23(2):105–111. doi: 10.2337/diab.23.2.105. [DOI] [PubMed] [Google Scholar]
  6. Goldstein J. L., Hazzard W. R., Schrott H. G., Bierman E. L., Motulsky A. G. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest. 1973 Jul;52(7):1533–1543. doi: 10.1172/JCI107331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kannel W. B., Castelli W. P., Gordon T., McNamara P. M. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med. 1971 Jan;74(1):1–12. doi: 10.7326/0003-4819-74-1-1. [DOI] [PubMed] [Google Scholar]
  8. Lewis B., Chait A., Oakley C. M., Wootton I. D., Krikler D. M., Onitiri A., Sigurdsson G., February A. Serum lipoprotein abnormalities in patients with ischaemic heart disease: comparisons with a control population. Br Med J. 1974 Aug 24;3(5929):489–493. doi: 10.1136/bmj.3.5929.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lewis B., Chait A., Wootton I. D., Oakley C. M., Krikler D. M., Sigurdsson G., February A., Maurer B., Birkhead J. Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet. 1974 Feb 2;1(7849):141–146. doi: 10.1016/s0140-6736(74)92438-6. [DOI] [PubMed] [Google Scholar]
  10. Mann J. I., Vessey M. P., Thorogood M., Doll S. R. Myocardial infarction in young women with special reference to oral contraceptive practice. Br Med J. 1975 May 3;2(5965):241–245. doi: 10.1136/bmj.2.5965.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Nikkilä E. A., Kekki M. Plasma triglyceride transport kinetics in diabetes mellitus. Metabolism. 1973 Jan;22(1):1–22. doi: 10.1016/0026-0495(73)90024-3. [DOI] [PubMed] [Google Scholar]
  12. Noble R. P. Electrophoretic separation of plasma lipoproteins in agarose gel. J Lipid Res. 1968 Nov;9(6):693–700. [PubMed] [Google Scholar]
  13. Oliver M. F. Ischaemic heart disease in young women. Br Med J. 1974 Nov 2;4(5939):253–259. doi: 10.1136/bmj.4.5939.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Parrish H. M., Carr C. A., Hall D. G., King T. M. Time interval from castration in premenopausal women to development of excessive coronary atherosclerosis. Am J Obstet Gynecol. 1967 Sep 15;99(2):155–162. doi: 10.1016/0002-9378(67)90314-6. [DOI] [PubMed] [Google Scholar]
  15. Patterson D., Slack J. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Lancet. 1972 Feb 19;1(7747):393–399. doi: 10.1016/s0140-6736(72)90853-7. [DOI] [PubMed] [Google Scholar]
  16. Rifkind B. M., Lawson D., Gale M. Diagnostic value of serum lipids and frequency of lipoprotein patterns in myocardial infarction. J Atheroscler Res. 1968 Jan-Feb;8(1):167–176. doi: 10.1016/s0368-1319(68)80090-0. [DOI] [PubMed] [Google Scholar]
  17. Utian W. H. Cholesterol, coronary heart disease and oestrogens. S Afr Med J. 1971 Apr 3;45(14):359–361. [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES